WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its financial results for the third quarter of fiscal year 2012 will be released before the market open on Wednesday, May 9, 2012, followed the same day by a conference call and live webcast scheduled for 8:30 a.m. ET.
